Literature DB >> 11894027

The important role of operations in the management of anaplastic thyroid carcinoma.

Kiminori Sugino1, Koichi Ito, Takashi Mimura, Mitsuji Nagahama, Nobuhiro Fukunari, Atsushi Kubo, Hiroyuki Iwasaki, Kunihiko Ito.   

Abstract

BACKGROUND: Anaplastic thyroid carcinoma is a rare and highly lethal neoplasm. We investigated whether operations have an impact on the survival of patients who have anaplastic carcinoma without distant metastasis.
METHODS: Between 1989 and 1999, 40 consecutive patients with anaplastic carcinoma, without distant metastasis at the time of presentation or during local treatment, were reviewed. The cumulative survival rates and 1-year survival rates were compared.
RESULTS: Eleven patients had a small focus of anaplastic carcinoma in a differentiated carcinoma, and 29 patients had ordinary anaplastic thyroid carcinoma. Surgical debulking was performed in 26 patients. Radiotherapy was used for 31 patients and chemotherapy for 19 patients. The 1-year survival rates of the patients with incidental anaplastic carcinoma, ordinary anaplastic carcinoma who underwent operations, and ordinary anaplastic carcinoma who did not undergo operations were 73%, 60%, and 21%, respectively. A significantly higher cumulative survival rate was observed in patients with incidental anaplastic carcinoma than in those with ordinary anaplastic carcinoma. A significantly better outcome was obtained by surgical debulking of ordinary anaplastic carcinoma.
CONCLUSIONS: Patients with incidental anaplastic carcinoma tended to have a good outcome, but some had a poor prognosis. Surgical debulking improved the outcome of patients with ordinary anaplastic carcinoma.

Entities:  

Mesh:

Year:  2002        PMID: 11894027     DOI: 10.1067/msy.2002.119936

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  18 in total

1.  Prognostic factors and treatment outcomes for anaplastic thyroid carcinoma: ATC Research Consortium of Japan cohort study of 677 patients.

Authors:  Iwao Sugitani; Akira Miyauchi; Kiminori Sugino; Takahiro Okamoto; Akira Yoshida; Shinichi Suzuki
Journal:  World J Surg       Date:  2012-06       Impact factor: 3.352

2.  The incidence and survival analysis for anaplastic thyroid cancer: a SEER database analysis.

Authors:  Bo Lin; Haiqing Ma; Maoguang Ma; Zhicheng Zhang; Zicheng Sun; I-Yun Hsieh; Okose Okenwa; Haoyan Guan; Jie Li; Weiming Lv
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

3.  Influence of risk grouping on therapeutic decisions in patients with anaplastic thyroid carcinoma.

Authors:  Chuanzheng Sun; Chao Li; Zedong Hu; Xiaojiang Li; Jiehua He; Ming Song; Guojun Li; Fenghua Zhang; Qiuli Li
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-10       Impact factor: 2.503

4.  Prognostic factors in anaplastic carcinoma of the thyroid-a multivariate survival analysis of 188 patients.

Authors:  Nikola Besic; Marko Hocevar; Janez Zgajnar; Ana Pogacnik; Snjezana Grazio-Frkovic; Marija Auersperg
Journal:  Langenbecks Arch Surg       Date:  2004-12-15       Impact factor: 3.445

5.  Nonconventional papillary thyroid carcinomas with pleomorphic tumor giant cells: a diagnostic pitfall with anaplastic carcinoma.

Authors:  Juliette Hommell-Fontaine; Angela Borda; Florence Ragage; Nicole Berger; Myriam Decaussin-Petrucci
Journal:  Virchows Arch       Date:  2010-04-23       Impact factor: 4.064

Review 6.  Anaplastic thyroid carcinoma: pathogenesis and emerging therapies.

Authors:  R C Smallridge; J A Copland
Journal:  Clin Oncol (R Coll Radiol)       Date:  2010-04-24       Impact factor: 4.126

Review 7.  German Association of Endocrine Surgeons practice guideline for the surgical management of malignant thyroid tumors.

Authors:  Henning Dralle; Thomas J Musholt; Jochen Schabram; Thomas Steinmüller; Andreja Frilling; Dietmar Simon; Peter E Goretzki; Bruno Niederle; Christian Scheuba; Thomas Clerici; Michael Hermann; Jochen Kußmann; Kerstin Lorenz; Christoph Nies; Peter Schabram; Arnold Trupka; Andreas Zielke; Wolfram Karges; Markus Luster; Kurt W Schmid; Dirk Vordermark; Hans-Joachim Schmoll; Reinhard Mühlenberg; Otmar Schober; Harald Rimmele; Andreas Machens
Journal:  Langenbecks Arch Surg       Date:  2013-03-03       Impact factor: 3.445

8.  Oncolytic vaccinia virotherapy of anaplastic thyroid cancer in vivo.

Authors:  Shu-Fu Lin; Daniel L Price; Chun-Hao Chen; Peter Brader; Sen Li; Lorena Gonzalez; Qian Zhang; Yong A Yu; Nanhai Chen; Aladar A Szalay; Yuman Fong; Richard J Wong
Journal:  J Clin Endocrinol Metab       Date:  2008-08-12       Impact factor: 5.958

Review 9.  Surgical options in undifferentiated thyroid carcinoma.

Authors:  Brian Hung-Hin Lang; Chung-Yau Lo
Journal:  World J Surg       Date:  2007-05       Impact factor: 3.352

Review 10.  Treatment of patients with anaplastic thyroid cancer during the last 20 years: whether any progress has been made?

Authors:  Vesna Bisof; Zoran Rakusic; Marija Despot
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-03       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.